BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31912808)

  • 21. Terpyridine Functionalized Cyclodextrin Nanoparticles as Carriers for Doxorubicin: Analysis of
    Viale M; Bertola N; Panebianco R; Vecchio G
    Anticancer Res; 2023 Dec; 43(12):5409-5414. PubMed ID: 38030189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
    Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
    Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
    Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
    J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indocyanine green/doxorubicin-encapsulated functionalized nanoparticles for effective combination therapy against human MDR breast cancer.
    Chen HH; Lu IL; Liu TI; Tsai YC; Chiang WH; Lin SC; Chiu HC
    Colloids Surf B Biointerfaces; 2019 May; 177():294-305. PubMed ID: 30771581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(styrene oxide)-poly(ethylene oxide) block copolymers: From "classical" chemotherapeutic nanocarriers to active cell-response inducers.
    Cambón A; Rey-Rico A; Barbosa S; Soltero JF; Yeates SG; Brea J; Loza MI; Alvarez-Lorenzo C; Concheiro A; Taboada P; Mosquera V
    J Control Release; 2013 Apr; 167(1):68-75. PubMed ID: 23352909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activatable Fluorescence Imaging and Targeted Drug Delivery via Extracellular Vesicle-Like Porous Coordination Polymer Nanoparticles.
    Wu Y; Zhang F; Wang K; Luo P; Wei Y; Liu S
    Anal Chem; 2019 Nov; 91(21):14036-14042. PubMed ID: 31603308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of l-Tyrosine-Based Enzyme-Responsive Amphiphilic Poly(ester-urethane) Nanocarriers for Multiple Drug Delivery to Cancer Cells.
    Aluri R; Jayakannan M
    Biomacromolecules; 2017 Jan; 18(1):189-200. PubMed ID: 28064504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities.
    Zhang J; Li J; Shi Z; Yang Y; Xie X; Lee SM; Wang Y; Leong KW; Chen M
    Acta Biomater; 2017 Aug; 58():349-364. PubMed ID: 28455219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH-responsive dithiomaleimide-amphiphilic block copolymer for drug delivery and cellular imaging.
    Bai T; Shao D; Chen J; Li Y; Xu BB; Kong J
    J Colloid Interface Sci; 2019 Sep; 552():439-447. PubMed ID: 31151021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved cytotoxicity and preserved level of cell death induced in colon cancer cells by doxorubicin after its conjugation with iron-oxide magnetic nanoparticles.
    Augustin E; Czubek B; Nowicka AM; Kowalczyk A; Stojek Z; Mazerska Z
    Toxicol In Vitro; 2016 Jun; 33():45-53. PubMed ID: 26911730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymeric-gold nanohybrids for combined imaging and cancer therapy.
    Topete A; Alatorre-Meda M; Villar-Alvarez EM; Carregal-Romero S; Barbosa S; Parak WJ; Taboada P; Mosquera V
    Adv Healthc Mater; 2014 Aug; 3(8):1309-25. PubMed ID: 24764284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Light-sensitive dextran-covered PNBA nanoparticles to continuously or discontinuously improve the drug release.
    Soliman SMA; El Founi M; Vanderesse R; Acherar S; Ferji K; Babin J; Six JL
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110393. PubMed ID: 31357128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
    Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
    Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery.
    Du JZ; Du XJ; Mao CQ; Wang J
    J Am Chem Soc; 2011 Nov; 133(44):17560-3. PubMed ID: 21985458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
    Metin E; Mutlu P; Gündüz U
    Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disulfide-cross-linked PEG-block-polypeptide nanoparticles with high drug loading content as glutathione-triggered anticancer drug nanocarriers.
    Chen YF; Chang CH; Lin CY; Lin LF; Yeh ML; Jan JS
    Colloids Surf B Biointerfaces; 2018 May; 165():172-181. PubMed ID: 29482128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of cyclic topology toward enhanced drug delivery, from linear and tadpole-like to dumbbell-shaped copolymers.
    Kang G; Liu Y; Li L; Sun L; Ma W; Meng C; Ma L; Zheng G; Chang C; Wei H
    Chem Commun (Camb); 2020 Mar; 56(20):3003-3006. PubMed ID: 32044897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polylactide-graft-doxorubicin nanoparticles with precisely controlled drug loading for pH-triggered drug delivery.
    Yu Y; Chen CK; Law WC; Weinheimer E; Sengupta S; Prasad PN; Cheng C
    Biomacromolecules; 2014 Feb; 15(2):524-32. PubMed ID: 24446700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(ethylene glycol) shell-sheddable TAT-modified core cross-linked nano-micelles: TAT-enhanced cellular uptake and lysosomal pH-triggered doxorubicin release.
    Zhang Y; Xiao Y; Huang Y; He Y; Xu Y; Lu W; Yu J
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110772. PubMed ID: 31999965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin.
    Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A
    Eur J Pharm Sci; 2007 Feb; 30(2):136-42. PubMed ID: 17218086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.